Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2

Ronghua Wang; Fangming Liu; Yongxu Zhao; Dan Wu; Lihan Chen; Edward T.H. Yeh; Chao Huang

doi:10.18632/oncotarget.19594

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2

Ronghua Wang, Fangming Liu, Yongxu Zhao, Dan Wu, Lihan Chen, Edward T.H. Yeh _ and Chao Huang

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:70142-70155. https://doi.org/10.18632/oncotarget.19594

Metrics: PDF 1625 views | HTML 2490 views | ?

Abstract

Ronghua Wang1,*, Fangming Liu1,*, Yongxu Zhao2,*, Dan Wu1, Lihan Chen2, Edward T.H. Yeh3 and Chao Huang1

1The Central Lab at Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

2Institute of Health Sciences, Chinese Academy of Sciences-Jiaotong University School of Medicine, Shanghai, China

3Department of Internal Medicine, The University of Missouri, Columbia, MO, USA

*These authors have contributed equally to this work

Correspondence to:

Edward T.H. Yeh, email: [email protected]

Chao Huang, email: [email protected]

Keywords: ORC2, SUMOylation, PIAS4, SENP2, polyploidy

Received: February 20, 2017 Accepted: June 20, 2017 Published: July 26, 2017

ABSTRACT

The small ubiquitin-related modifier (SUMO) system is essential for smooth progression of cell cycle at the G2/M phase. Many centromeric proteins are reversibly SUMOylated to ensure proper chromosome segregation at the mitosis. SUMOylation of centromeric Origin Recognition Complex subunit 2 (ORC2) at the G2/M phase is essential in maintaining genome integrity. However, how ORC2 SUMOylation is regulated remains largely unclear. Here we show that ORC2 SUMOylation is reversibly controlled by SUMO E3 ligase PIAS4 and De-SUMOylase SENP2. Either depletion of PIAS4 or overexpression of SENP2 eliminated SUMOylation of ORC2 at the G/M phase and consequently resulted in abnormal centromeric histone H3 lysine 4 methylation. Cells stably expressing SENP2 protein or small interfering RNA for PIAS4 bypassed mitosis and endoreduplicated their genome to become polyploidy. Furthermore, percentage of polyploid cells is reduced after coexpression of ORC2-SUMO2 fusion protein. Thus, the proper regulation of ORC2 SUMOylation at the G2/M phase by PIAS4 and SENP2 is critical for smooth progression of the mitotic cycle of cells.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19594

Publication Alerts

Research Papers:

Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2

Abstract